Catalyst Pharmaceuticals Inc (CPRX)
21.74
-0.15
(-0.69%)
USD |
NASDAQ |
Nov 04, 16:00
21.74
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap: 2.581B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.598B |
| October 31, 2024 | 2.587B |
| October 30, 2024 | 2.559B |
| October 29, 2024 | 2.584B |
| October 28, 2024 | 2.595B |
| October 25, 2024 | 2.547B |
| October 24, 2024 | 2.541B |
| October 23, 2024 | 2.533B |
| October 22, 2024 | 2.547B |
| October 21, 2024 | 2.495B |
| October 18, 2024 | 2.521B |
| October 17, 2024 | 2.511B |
| October 16, 2024 | 2.572B |
| October 15, 2024 | 2.514B |
| October 14, 2024 | 2.450B |
| October 11, 2024 | 2.397B |
| October 10, 2024 | 2.363B |
| October 09, 2024 | 2.370B |
| October 08, 2024 | 2.383B |
| October 07, 2024 | 2.342B |
| October 04, 2024 | 2.374B |
| October 03, 2024 | 2.360B |
| October 02, 2024 | 2.374B |
| October 01, 2024 | 2.400B |
| September 30, 2024 | 2.360B |
| Date | Value |
|---|---|
| September 27, 2024 | 2.322B |
| September 26, 2024 | 2.368B |
| September 25, 2024 | 2.374B |
| September 24, 2024 | 2.433B |
| September 23, 2024 | 2.432B |
| September 20, 2024 | 2.468B |
| September 19, 2024 | 2.534B |
| September 18, 2024 | 2.425B |
| September 17, 2024 | 2.426B |
| September 16, 2024 | 2.426B |
| September 13, 2024 | 2.400B |
| September 12, 2024 | 2.408B |
| September 11, 2024 | 2.310B |
| September 10, 2024 | 2.299B |
| September 09, 2024 | 2.332B |
| September 06, 2024 | 2.326B |
| September 05, 2024 | 2.352B |
| September 04, 2024 | 2.363B |
| September 03, 2024 | 2.343B |
| August 30, 2024 | 2.403B |
| August 29, 2024 | 2.371B |
| August 28, 2024 | 2.419B |
| August 27, 2024 | 2.430B |
| August 26, 2024 | 2.439B |
| August 23, 2024 | 2.412B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
269.90M
Minimum
Mar 16 2020
2.598B
Maximum
Nov 01 2024
1.066B
Average
787.38M
Median
Market Cap Benchmarks
| Sarepta Therapeutics Inc | 11.74B |
| Vertex Pharmaceuticals Inc | 122.16B |
| Regenxbio Inc | 433.44M |
| Edgewise Therapeutics Inc | 3.235B |
| Entrada Therapeutics Inc | 660.11M |
Market Cap Related Metrics
| PE Ratio | 40.27 |
| PS Ratio | 5.861 |
| Price to Book Value | 4.240 |
| Price to Free Cash Flow | 22.15 |
| Price | 21.74 |
| Earnings Yield | 2.48% |
| Operating PE Ratio | 29.65 |
| Normalized PE Ratio | 39.30 |